5,7,3',4'-tetramethylluteolin

a flavonoid from the East Asian medicinal plant Orthosiphon spicatus; prevents oxidative inactivation of 15-lipoxygenase; structure given in first source

Also Known As:

3',4',5,7-tetramethoxyflavone; 3',4',5,7-tetramethyl-luteolin

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        Flavones: 446
        Luteolin: 1323
        5,7,3',4'-tetramethylluteolin: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        Flavones: 446
        Luteolin: 1323
        5,7,3',4'-tetramethylluteolin: 1

Experts

1.	Patel, Arti B: 1 article (01/2017)
2.	Theoharides, Theoharis C: 1 article (01/2017)

Related Diseases

1.	type 2C Congenital disorder of glycosylation 01/01/2017 - "Here, we investigate the role of mammalian target of rapamycin (mTOR) signaling in the stimulation of cultured human LAD2 MCs by NT or SP, as well as the inhibitory effect of the natural flavonoids 3',4',5,7-tetrahydroxyflavone (luteolin) and its novel structural analog 3',4',5,7-tetramethoxyflavone (methoxyluteolin). "

Related Drugs and Biologics

1.	TOR Serine-Threonine Kinases
2.	Luteolin
3.	Flavonoids
4.	methoxyluteolin